Company / Return on Assets (ROA)
ANI Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
5.4%
FY2025
5-year range
-6.3% / 5.4%
FY2021-FY2025
Trend
+477.8%
vs FY2024
Sector context
#37 of 213
Health Care
What the data says
Return on Assets (ROA) changed +478% YoY in FY2025, a notable deviation from the 9-year average annual change of +139%.
Based on SEC 10-K filings.
5.4% in FY2025 with a 5-year CAGR of +10.3%. Top quartile in the Health Care sector.
Improved from 2.1% to 5.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +11.7pp
- 5-Year Change
- +10.3pp
- 10-Year Change
- -
Sector benchmark
Top 17% in Health CareTop 17% of 213This company 5.4% Sector average -24.1%
▼
+122.5% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 477.8% year-over-year.
- Currently 29.6pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.4% | +477.8% |
| FY2024 | -1.4% | -169.2% |
| FY2023 | 2.1% | +133.0% |
| FY2022 | -6.3% | -14.1% |
| FY2021 | -5.5% | -12.9% |
| FY2020 | -4.9% | -467.7% |
| FY2019 | 1.3% | -63.1% |
| FY2018 | 3.6% | +1484.6% |
| FY2017 | -0.3% | -121.3% |
| FY2016 | 1.2% | +1009.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026